Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Status:
Terminated
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This protocol is a phase I/II, study of ascorbic acid (AA) infusions combined with treatment
with irinotecan versus treatment with irinotecan alone in patients with recurrent or advanced
colorectal cancer who have failed at least one treatment regimen with a 5-FU based therapy.
This study will be conducted as an amendment to Investigational New Drug # 77486.